3rd Oct 2013 06:47
LONDON (Alliance News) - Healthcare company BTG Plc (BTG.L) Thursday said its financial performance for the first half has been in line with board's expectations, and lifted its full-year revenue guidance, following recent acquisitions.
The company stated that overall, the business is in great shape and looks forward to continued progress in the second half year.
For the full fiscal year, the firm currently expects revenues to be in the range of 275 million pounds to 285 million pounds, up from the prior guidance of 235 million pounds to 245 million pounds.
BTG noted that it has made good progress in integrating Targeted Therapies division of Nordion, Inc. and EKOS Corp.,, both acquisitions having completed in July 2013.
Louise Makin, CEO of BTG said, "We have made a strong start to the year with a good financial performance across our operating segments. We expanded our portfolio with the acquisitions of TheraSphere and EKOS and the integration of both businesses is on track."
The company is scheduled to publish its interim results on November 12.
Copyright RTT News/dpa-AFX
Related Shares:
BTG